References
- 1
Nielsen H J.
Clinical impact of bioactive substances in blood components: Implications for leukocyte
filtration.
Infuther Transfusion Med..
1998;
25
296-304
- 2
Lee T H, Paglieroni T, Ohto H, Holland P V, Busch M P.
Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients:
Frequent long-term microchimerism in severe trauma patients.
Blood.
1999;
93
3127-3139
- 3 Busch M P, Lee T H. Role of donor leukocytes and leukodepletion in transfusion-associated
viral infections. In: Sweeney J, Heaton A (eds). Clinical benefits of leukodepleted
blood products. R.G.Landers Company, New York 1995: 97-112
- 4
Holmgren L, Szeles A, Rajnavolgyi E. et al .
Horizontal transfer of DNA by uptake of apoptotic bodies.
Blood.
1999;
93
3956-3963
- 5
Nusbacher J.
Blood transfusion is mononuclear cell transplantation.
Transfusion.
1994;
34
1002-1006
- 6
Nielsen H J.
Detrimental effect of perioperative blood transfusion.
Br. J. Surg..
1995;
82
582-587
- 7
Agarwal N, Murphy J G, Cayton C G, Stahl W M.
Blood transfusion increases the risk of infection after trauma.
Arch. Surg..
1993;
128
171-177
- 8
Meakins J L.
Surgeons, surgery and immunomodulation.
Arch. Surg..
1991;
126
494-498
- 9
Amato A C, Pescatori M.
Effect of perioperative blood transfusions on recurrence of colorectal cancer. Meta-analysis
stratified on risk factors.
Dis. Colon. Rectum..
1998;
41
570-585
- 10 Mynster T, Christensen I J, Nielsen H J. Blood transfusion-related postoperative
infections and prognosis after elective colorectal cancer surgery. Br J Surg 2000
(in press)
- 11
Carson J L, Altman D G, Duff A. et al .
Risk of bacterial infection associated with allogeneic blood transfusion among patients
undergoing hip fracture repair.
Transfusion.
1999;
39
694-700
- 12
Ness P M, Walsh P C, Zahurak M, Baldwin M L, Piantadosi S.
Prostate cancer recurrence in radical surgery patients receiving autologous or homologous
blood.
Transfusion.
1992;
32
31-36
- 13
Busch O RC, Hop W CJ, Hoynch van Papendrecht M AW, Marquet R L, Jeekle J.
Blood transfusion and prognosis in colorectal cancer.
N. Engl. J. Med..
1993;
328
1372-1376
- 14
Domen R E.
Adverse reactions associated with autologous blood transfusion: evaluation and incidence
at a large academic hospital.
Transfusion.
1998;
38
296-300
- 15
Etchason J, Petz L, Keeler E. et al .
The cost effectiveness of preoperative autologous blood donation.
N. Engl. J. Med..
1995;
32
719-724
- 16
Allen S.
The role of leucocytes in the systemic inflammatory response and the potential impact
of leucocyte reduction.
Cardiovasc Engineering.
1997;
2
34-54
- 17
Hyllner M, Arnestad J P, Rydberg L, Bengtson A.
Complement activation during storage of whole blood, red cells, plasma and buffy-coat.
Transfusion.
1997;
37
264-268
- 18
Nielsen H J, Krarup A L, Munk-Nielsen L. et al .
Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substances
accumulation in patients operated for burn trauma.
Burns.
1999;
25
162-170
- 19
Nielsen H J.
Histamine-2 receptor antagonist as immunomodulators - New therapeutic views?.
Ann. Med..
1996;
28
107-113
- 20
Bajou K, Noël A, Gerred R. et al .
Absence of host plasminogen activator inhibitor-1 prevents cancer invasion and neovascularisation.
Nature Med..
1998;
4
923-928
- 21 Werther K, Brünner N, Christensen I J, Nielsen H J. The prognostic impact of perioperative
blood transfusion and preoperative soluble VEGF in patients undergoing resection for
primary colorectal cancer. Eur J Surg Oncol 2000 (in press)
- 22
Nielsen H J, Edvardsen L, Vangsgaard K, Dybjaer E, Skov R S.
Time-dependent histamine release from stored human blood products.
Br. J. Surg..
1996;
83
257-262
- 23
Nielsen H J, Reimert C M, Pedersen A N. et al .
Time-dependent, spontaneous release of leukocyte- and platelet-derived bioactive substances
from stored human blood.
Transfusion.
1996;
36
960-965
- 24
Edvardsen L, Nielsen H J, Dybkjaer E. et al .
Leukocyte and platelet derived bioactive substances in stored standard platelet concentrates.
Eur. J. Haematol..
1996;
56
185-187
- 25
Nielsen H J, REimert C M, Pedersen A N. et al .
Leucocyte-derived bioactive substances in fresh frozen plasma.
Br. J. Anaesth..
1997;
78
548-552
- 26
Edvardsen L, Taaning E, Mynster T, Pedersen A N, Drachman O, Nielsen H J.
Bioactive substances in buffy-coat derived platelets pools stored in platelet additive
solutions.
Br. J. Haematol..
1998;
103
445-448
- 27 Nielsen H J, Werther K, Mynster T, Brünner N. Soluble vascular endothelial growth
factor in various blood transfusion components. Transfusion 1999 39: 1078-1083
- 28 Edwardsen L, Taaning E, Gammelgaard B D, Dalh Christesen L, Mynster T, Nielsen H J.
Extracellular accumulation of bioactive substances during preparation and storage
of various platelet concentrates. Transfusion 1999 (still in press)
- 29
Purdy F R, Tweedale M G, Merrick P M.
Association of mortality with age of blood transfused in septic ICU patients.
Can. J. Surg..
1997;
44
1256-1261
- 30
Mynster T, Dybkjaer E, Kronborg G, Nielsen H J.
Immunomodulating effect of blood transfusion. Is blood storage time important?.
Vox Sang.
1998;
74
176-181
- 31
Vamvakas E C, Carven J H.
Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: Effect
of the lenght of storage of transfused red cells.
Transfusion.
1999;
39
701-710
- 32 Mynster T, Nielssen H J. The impact of storage time of transfused blood on postoperative
infectious complications in rectal cancer surgery. Scand. J. Gastroenterol. 2000 35:
212-217
- 33
Hammer J H, Mynster T, Reimert C M. et al .
The effect of active heating on accumulation of extracellular bioactive substances
in transfused blood.
J. Trauma.
1997;
43
799-803
- 34
Hammer J H, Mynster T, Reimert C M, Brünner N, Nielsen H J.
Reduction of bioactive substances in donor blood. Prestorage versus bedside leucofiltration.
Eur. J. Haematol..
1999;
63
29-34
- 35 Mynster T, Hammer J H, Nielsen H J. Prestorage and bedside leukofiltration of whole
blood modulates storage time dependent suppression of in vitro TNF-α release. Br.
J. Haematol. 1999 106: 248-251
- 36
Bordin J O, Bardossy L, Blajchman M A.
Growth enhancement of established tumors by allogeneic blood transfusion in experimental
animals and its amelioration be leukodepletion.
Blood.
1994;
84
344-348
- 37 Sirchia G, Giovanetti A M, McClelland B, Fracchia G N. Safe and good use of blood
in surgery (SANGUIS). Use of blood and artificial colloids in 43 European hospitals. Council
of Europe Publishing 1994: 1-235
- 38
Hébert P C, Wells G, Blajchman M A. et al .
A multicenter, randomized, controlled clinical trial of transfusion requirements in
critical care.
N. Engl. J. Med..
1999;
340
409-417
- 39
Carson J L, Duff A, Berlin J A. et al .
Perioperative blood transfusion and postoperative mortality.
JAMA.
1998;
279
199-205
H. J. Nielsen
Dept. of Surg. Gastroenterology, 435
Hvidovre University Hospital
2650 Hvidovre, Denmark
Email: h.j.nielsen@forum.dk
